Bioanalysis, a leading MEDLINE indexed journal for bioanalysts, has published a Special Focus Issue on Methods & Techniques for Metabolic Phenotyping. The issue contains a variety of content focusing on multi-analyte measurement of endogenous metabolites, covering technologies used for the analysis of complex biological samples. The journal is published by Future Science Group.
Ian Wilson (Imperial College, UK), Guest Editor of the Special Focus Issue commented, "…it is difficult to imagine a future for precision medicine that does not include metabolic phenotyping as a source of new biomarkers … the combination of high-throughput analytical methods for obtaining metabolic phenotypes ('metabotypes') and advanced statistical techniques has provided a range of new tools for the discovery of novel biomarkers, we just have to use them intelligently…"
The Special Focus issue contains a range of content including general reviews and research articles describing methods using both 'untargeted' metabotyping, specific targeted approaches, and potential new approaches.
"We are excited to be publishing this timely Special Focus Issue of Bioanalysis" said Sankeetha Nadarajah, Editor of the journal. "The issue aims to highlight current applications and advances in the field of metabolic phenotyping, while also providing an outlook on how the field is likely to evolve."
To read the full issue, please click here – http://www.future-science.com/toc/bio/8/24
Bioanalysis is a MEDLINE-indexed journal covering the latest scientific, technical and regulatory developments relevant to those working on the analysis of xenobiotics and biotics in biological matrices. This is, primarily, bioanalysts working in pharmaceutical research and development, clinical laboratories, clinical toxicologists, forensic toxicologists and sports doping analysts.
About Bioanalysis Zone
Since launching in 2011, Bioanalysis Zone has attracted over 7,500 active members from the global bioanalytical community, representing the pharmaceutical, biotech and CRO industries, along with academia and healthcare. Each month, thousands of members visit the site to read industry news, original research exclusive interviews and commentaries. Membership is completely free of charge. Sign up online at: http://www.bioanalysis-zone.com/register.
About Future Science Group
Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. FSG's portfolio includes two imprints, Future Science and Future Medicine. In addition to this core publishing business, FSG develops specialist eCommunities. Key titles and sites include Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine. http://www.futuresciencegroup.com.
The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards. http://www.future-science-group.com.
Story Source: Materials provided by Scienmag